SONEX RESEARCH INC
10QSB, 2000-05-10
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: FIDELITY ADVISOR SERIES I, 485APOS, 2000-05-10
Next: SSI SURGICAL SERVICES INC, 10-Q, 2000-05-10












                     U.S. SECURITIES AND EXCHANGE COMMISSION
                             Washington, D. C. 20549


                                   FORM 10-QSB


                  QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF
                       THE SECURITIES EXCHANGE ACT OF 1934

               For the quarterly period ended March 31, 2000.




                              SONEX RESEARCH, INC.



                      Incorporated in the State of Maryland
                                23 Hudson Street
                            Annapolis, Maryland 21401


                        Telephone Number: (410) 266-5556
                   IRS Employer Identification No. 52-1188993


                         Commission file number 0-14465






Check  whether the Issuer (1) filed all reports  required to be filed by Section
13 or 15(d) of the Exchange Act during the preceding 12 months, and (2) has been
subject to such filing requirements for the past 90 days.

                                            YES   [x]       NO   [ ]



There  were  18,317,299 shares  of the  Issuer's  $.01 par value  Common  Stock
outstanding at May 1, 2000.



























                                      - 1 -
<PAGE>
                        SONEX RESEARCH, INC. FORM 10-QSB







                         PART I - FINANCIAL INFORMATION





ITEM 1.  FINANCIAL STATEMENTS (Unaudited)


Index to unaudited financial statements presented on pages 2 to 9:

     Report of Independent Accountants

     Balance sheets as of March 31, 2000 and December 31, 1999

     Statements of operations and accumulated deficit for the three- month
     periods ended March 31, 2000 and 1999

     Statements of paid-in capital for the period from January 1, 1998 through
     March 31, 2000

     Statements of cash flows for the three-month periods ended March 31, 2000
     and 1999

     Notes to financial statements



                        REPORT OF INDEPENDENT ACCOUNTANTS


To the Board of Directors and Stockholders of Sonex Research, Inc.

We have reviewed the condensed financial statements appearing on pages 3 through
10 of this Form 10Q-SB Quarterly Report of Sonex Research,  Inc. (the "Company")
as of March 31, 2000. These financial  statements are the  responsibility of the
Company's management.

We conducted our review in accordance with standards established by the American
Institute  of  Certified  Public  Accountants.  A review  of  interim  financial
information consists principally of applying analytical  procedures to financial
data and making  inquiries of persons  responsible  for financial and accounting
matters. It is substantially less in scope than an audit conducted in accordance
with  generally  accepted  auditing  standards,  the  objective  of which is the
expression of an opinion  regarding the financial  statements  taken as a whole.
Accordingly, we do not express such an opinion.

Based on our review, we are not aware of any material  modifications that should
be made to the  accompanying  financial  statements for them to be in conformity
with generally accepted accounting principles.

We previously audited, in accordance with generally accepted auditing standards,
the balance  sheet as of  December  31,  1999,  and the  related  statements  of
operations and  accumulated  deficit and cash flows for the year then ended (the
"audited financial  statements",  not presented herein), and in our report dated
March  2,  2000,  we  expressed  an  unqualified   opinion  on  those  financial
statements.  We also stated that the audited financial  statements were prepared
assuming  that  the  Company  will  continue  as a going  concern;  however,  as
described  in  Note 3 to the  audited  financial  statements,  the  Company  has
incurred  significant net losses since its inception and its ability to commence
generation of significant  revenue and ultimately achieve profitable  operations
raise  substantial  doubt  about the  Company's  ability to  continue as a going
concern.  The  audited  financial  statements  and  the  accompanying  condensed
financial  statements do not include any adjustments  that might result from the
outcome of this uncertainty.

C. L. STEWART & COMPANY
Annapolis, Maryland
May 1, 2000








                                     - 2 -
<PAGE>
                        SONEX RESEARCH, INC. FORM 10-QSB



                              SONEX RESEARCH, INC.
                            CONDENSED BALANCE SHEETS
                                   (Unaudited)


                                                       March 31,   December 31,
                           ASSETS                        2000         1999
                                                     ------------  ------------

Current assets
 Cash and equivalents                                $    102,197  $     57,768
 Accounts receivable                                      149,992        77,461
 Prepaid expenses                                          27,153        29,836
 Loans to officers and employees                           22,500        22,500
                                                     ------------  ------------
   Total current assets                                   301,842       187,565

Patents and technology, net of accumulated
  amortization of $40,576 in 2000 and
  $68,746 in 1999                                         190,516       219,776

Property and equipment, net of accumulated
  depreciation of $413,675 in 2000 and
  $409,648 in 1999                                         80,111        83,968
                                                     ------------  ------------

           Total assets                              $    572,469  $    491,309
                                                     ============  ============


     LIABILITIES AND STOCKHOLDERS' EQUITY/(DEFICIT)

Current liabilities
 Accounts payable and other accrued liabilities      $     76,508  $     49,212
 Accrued wages, bonuses and vacation pay                   69,000        79,381
                                                     ------------  ------------
     Total current liabilities                            145,508       128,593
                                                     ------------  ------------

Deferred compensation                                     776,425       763,744
                                                     ------------  ------------

Stockholders' equity/(deficit)
 Preferred stock, $.01 par value - 2,000,000
   shares issued; 1,540,001 shares outstanding             15,400        15,400
 Common stock, $.01 par value - shares issued
   and outstanding: 18,317,299 in 2000 and
   18,008,169 in 1999                                     183,173       180,082
 Additional paid-in capital                            20,550,942    20,430,476
 Accumulated deficit                                  (21,098,979)  (21,026,986)
                                                     ------------  ------------
   Total stockholders' equity/(deficit)                  (349,464)     (401,028)
                                                     ------------  ------------

   Total liabilities and stockholders' equity        $    572,469  $    491,309
                                                     ============  ============























    The accompanying notes are an integral part of the financial statements.

                                      - 3 -
<PAGE>
                        SONEX RESEARCH, INC. FORM 10-QSB



                              SONEX RESEARCH, INC.
           CONDENSED STATEMENTS OF OPERATIONS AND ACCUMULATED DEFICIT
                                   (Unaudited)




                                                 Three months ended March 31,
                                                 ----------------------------
                                                   2000                1999
                                                   ----                ----

Development and demonstration revenue
  Government                                  $    195,005        $     38,800
  Commercial                                        20,000
                                              ------------        ------------
                                                   215,005              38,800
                                              ------------        ------------
Costs and expenses
  Cost of revenue                                  110,289              16,135
  Research and development                         101,495             140,462
  General and administrative                        75,816              83,404
                                              ------------        ------------

                                                   287,600             240,001
                                              ------------        ------------

Net loss from operations                           (72,595)           (201,201)

Other income and expense
  Investment and other income                          602               3,186
  Gain on sale of marketable securities
                                              ------------        ------------

Net loss                                           (71,993)           (198,015)

Accumulated deficit
  Beginning of period                          (21,026,986)        (20,456,871)
                                              -------------       ------------

  End of period                               $(21,098,979)       $(20,654,886)
                                              ============        ============


Net loss per share                                   $.004               $.011
                                                     =====               =====


Weighted average number of common
  shares outstanding                            18,152,500          17,642,435
                                              ============        ============




























   The accompanying notes are an integral part of the financial statements.

                                      - 4 -
<PAGE>
                        SONEX RESEARCH, INC. FORM 10-QSB



                              SONEX RESEARCH, INC.
                     CONDENSED STATEMENTS OF PAID-IN CAPITAL
                                   (Unaudited)



                          Price  Preferred stock    Common stock     Additional
                           per  ($.01 par value)  ($.01 par value)     paid-in
                          share  Shares   Amount   Shares    Amount    capital
                          ----- --------- ------ ---------- -------  ----------

Balance, January 1, 1998        1,540,001$15,400 17,393,906$173,939 $20,035,060

January through December -
 option exercises          $.50                     181,500   1,815      88,935
March for services          .625                     20,000     200      12,300
June for services           .75                       7,949      80       5,882
September for services      .44                      26,813     268      11,463
December for services       .50                      12,692     127       6,219
Stock option compensation                                                 5,000
Amortization of deferred
 compensation from grant of
 stock options                                                           44,644
                                --------- ------ ---------- -------  ----------
Balance, December 31, 1998      1,540,001 15,400 17,642,860 176,429  20,209,503

March for services          .44                      20,975     210       9,098
June for services           .46                      17,925     179       8,071
September for services      .38                      36,923     369      13,593
December for services       .32                      36,803     368      11,478
April and December
 option exercises           .50                     255,000   2,550     124,950
Correction of stock ledger                           (2,317)    (23)         23
Stock option compensation                                                24,000
Amortization of deferred
 compensation from grant of
 stock options                                                           29,760
                                --------- ------ ----------  -------  ----------

Balance, December 31, 1999      1,540,001 15,400 18,008,169 180,082  20,430,476

February exercise of
 warrants                   .35                     285,000   2,850      96,900
March for services          .40                      24,130     241      10,125
Stock option compensation                                                 6,000
Amortization of deferred
 compensation from grant of
 stock options                                                            7,441
                                --------- ------ ---------- -------  ----------

Balance, March 31, 2000         1,540,001$15,400 18,317,299$183,173 $20,550,942
                                ========= ====== ========== ======= ===========



























    The accompanying notes are an integral part of the financial statements.

                                      - 5 -
<PAGE>
                        SONEX RESEARCH, INC. FORM 10-QSB



                              SONEX RESEARCH, INC.
                       CONDENSED STATEMENTS OF CASH FLOWS
                                   (Unaudited)



                                                          Three months ended
                                                               March 31,
                                                      -------------------------
                                                           2000          1999
                                                           ----          ----

Cash flows from operating activities
 Net loss                                             $    (71,993)  $ (198,015)
 Adjustments to reconcile net loss to
  net cash used by operating activities
   Depreciation                                              4,972        2,250
   Amortization of patents and technology                   29,260        3,150
   Amortization of deferred compensation
    from stock options                                       7,441        7,440
   Current charges paid in stock or options                 16,366       15,308
   Gain on sale of marketable securities
   (Increase) decrease in accounts receivable              (72,531)       9,015
   (Increase) decrease in prepaid expenses                   2,683          758
   Increase (decrease) in current liabilities               16,916      (12,765)
   Increase (decrease) in deferred compensation             12,680       13,565
                                                      ------------   -----------
Net cash used in operating activities                      (54,206)    (159,294)
                                                      ------------   -----------

Cash flows from investing activities
   Proceeds from sales of marketable securities
   (Increase) decrease in loans to employees                              5,000
   Acquisition of property and equipment                    (1,115)      (1,936)
   Additions to patents and technology                                   (1,027)
                                                      ------------   ----------
Net cash provided by (used in) investing activities         (1,115)       2,037
                                                      ------------   ----------

Cash flows from financing activities
   Issuance of stock - exercise of warrants                 99,750
   Issuance of stock - exercise of options
                                                      ------------   ----------
Net cash provided by financing activities                   99,750            0
                                                      ------------   ----------

Increase (decrease) in cash                                 44,429     (157,257)

Cash
   Beginning of period                                      57,768      336,458
                                                      ------------   ----------
   End of period                                      $    102,197   $  179,201
                                                      ============   ==========


























    The accompanying notes are an integral part of the financial statements.

                                      - 6 -
<PAGE>
                        SONEX RESEARCH, INC. FORM 10-QSB



                              SONEX RESEARCH, INC
                     NOTES TO CONDENSED FINANCIAL STATEMENTS
                                   (Unaudited)


Note 1 - The Company
- --------------------

     Sonex Research, Inc. has developed a proprietary  technology,  known as the
Sonex Combustion System (SCS), which improves the combustion of fuel in internal
combustion  engines through  modification of the pistons in large engines or the
cylinder heads in small  engines.  Variations of the Company's  technology  have
been applied to all types of internal combustion  engines,  including those used
in personal and commercial vehicles as well as engines used in fixed or portable
utility   applications.   Sonex  concentrates  its  commercial  efforts  on  the
application of the SCS to the reduction of exhaust  emissions in direct injected
turbocharged  diesel  engines.  The  Company's  objective  is to  execute  broad
agreements with engine  manufacturers  and their piston suppliers for industrial
production of SCS pistons under license from Sonex.


Note 2 - Presentation of Financial Statements
- ---------------------------------------------

     The  accompanying   unaudited  condensed  financial  statements  have  been
prepared in accordance with generally accepted accounting principles for interim
financial  information and with the  instructions to Form 10-QSB and Item 310(b)
of Regulation S-B. Accordingly, these financial statements do not include all of
the  information  and  footnotes  required  by  generally  accepted   accounting
principles for complete financial statements. In the opinion of management,  all
adjustments (consisting of normal recurring accruals) considered necessary for a
fair presentation have been included.

     Operating  results for the three-month  period ended March 31, 2000 are not
necessarily  indicative  of the results that may be expected for the year ending
December 31, 2000. For further  information,  reference is made to the financial
statements  and notes thereto  included in the  Company's  Annual Report on Form
10-KSB for the year ended December 31, 1999.

     Certain  reclassifications  have been made to the  prior  period  financial
statements to conform to the classifications used in the current period.


Note 3 - Patents
- ----------------

     The costs  associated with the filing of patent  applications are deferred.
Amortization is recorded on a straight-line  basis over the remaining legal life
of patents, commencing in the year in which the patent is granted. Costs related
to patent applications which ultimately fail to result in the grant of a patent,
either through  rejection by patent  authorities  or through  abandonment by the
Company, are charged to operations at the time such determination is made.


Note 4 - Deferred Compensation
- ------------------------------

       In order to help conserve the Company's  limited cash resources,  certain
of the Company's  employees for several years have voluntarily  deferred receipt
of payment of  significant  portions of their  authorized  annual  salaries upon
request by the Board of Directors.  By written agreement with the Company, these
individuals  have consented to the deferral of payment of amounts so accumulated
until the Company has  received  licensing  revenue of at least $2 million or at
such earlier date as the Board of Directors  determines  that the Company's cash
flow is sufficient to allow such payment.  Since January 1, 1997, however, there
has been no further deferral of salary requested of the Company's  non-executive
employees.

     Deferred   compensation   outstanding   is   payable   to   the   following
classifications of personnel:

                                                      March 31,
                                                      ---------
                                                 2000            1999
                                                 ----            ----

        Current executive officers            $ 443,818       $ 431,137
        Current employees and consultants        62,088          62,088
        Former employees                        270,519         270,519
                                              ---------       ---------
                                              $ 776,425       $ 763,744
                                              =========       =========




                                     - 7 -
<PAGE>
                        SONEX RESEARCH, INC. FORM 10-QSB



Note 5 - Income Taxes
- ---------------------

        The Company has not incurred any federal or state income taxes since its
inception  due to operating  losses.  At December 31, 1999,  the Company had net
operating loss ("NOL") and capital loss  carryforwards  of  approximately  $16.2
million  available  to offset  future  taxable  income.  If certain  substantial
changes  in the  Company's  ownership  should  occur,  there  would be an annual
limitation  on the  amount  of the  carryforwards  which  can be  utilized.  The
Company's tax loss carryforwards are summarized as follows:


             Expiration                     NOL           Capital
             ----------                    -----          -------

                2000                  $  1,105,399
                2001                     1,748,874       $ 201,681
                2002                     1,837,965         133,400
                2003                     1,344,816         365,147
                2004                     1,185,181          14,970
             2005 - 2012                 7,995,726
             2018 - 2019                   941,695
                                      ------------       ---------

                                      $ 16,159,656       $ 715,198
                                      ============       =========


Note 6 - Stockholders' Equity
- -----------------------------

Authorized capital stock

     The Company is presently  authorized to issue 48 million shares of $.01 par
value common stock and 2 million shares of $.01 par value convertible  preferred
stock. All of the authorized shares of preferred stock,  along with common stock
purchase  warrants,  were issued for $2 million in February 1992 (the "Preferred
Stock Investment") to a small number of investors, including Proactive Partners,
L.P.  and  certain of its  affiliates  ("Proactive"),  who  became  the  largest
beneficial  owner of the Company's  common stock by virtue of the acquisition of
the convertible preferred stock and common stock purchase warrants.

     The preferred stock has priority in liquidation  over the common stock, but
it carries no stated dividend.  The holders of the preferred stock,  voting as a
separate class,  have the right to elect that number of directors of the Company
which  represents a majority of the total  number of  directors.  The  preferred
stock is  convertible  at any time at the option of the holder into common stock
at the rate of $.35 per share of common stock.  As of March 31, 2000, a total of
459,999 shares of preferred  stock had been  converted into 1,314,278  shares of
common stock.


Exercise and expiration of warrants

     In February  2000 the Company  received  cash  proceeds of $99,750 from the
exercise of stock warrants to purchase  285,000 shares of its common stock at an
exercise  price of $.35 per share.  At the same time,  warrants  to  purchase an
additional 286,428 shares at $.35 per share expired unexercised, as did warrants
to purchase 3,098,209 shares at $.75 per share.


Stock options

       The Company  maintains a  non-qualified  stock  option plan (the  "Plan")
which has made  available  for issuance a total of 7.5 million  shares of common
stock.  All directors,  full-time  employees and  consultants to the Company are
eligible for  participation.  Option awards are  determined at the discretion of
the Board of Directors. Upon a change in control of the Company, all outstanding
options  granted to employees and directors  become vested with respect to those
options which have not already  vested.  Options  outstanding  expire at various
dates through December 2009.

       The Company  accounts for  stock-based  compensation  using the intrinsic
value method  prescribed  in Accounting  Principles  Board (APB) Opinion No. 25.
Under APB No. 25,  compensation  cost is measured as the excess,  if any, of the
quoted  market  price of the  Company's  stock  at the  date of  grant  over the
exercise price of the option granted.  Compensation  cost for stock options,  if
any, is  recognized  ratably over the vesting  period.  In its  complete  annual
financial  statements  presented  in  its  Form  10-KSB,  the  Company  provides
additional  pro forma  disclosures  as required  under  Statement  of  Financial
Accounting  Standards No. 123 - "Accounting for Stock-Based  Compensation" as if
the fair value based  method of  accounting  had been  applied to the  Company's
stock option grants made subsequent to 1994.



                                      - 8 -
<PAGE>
                        SONEX RESEARCH, INC. FORM 10-QSB





       From  January  1,  2000  through  March 31,  2000,  the  Company  had the
following activity in options to purchase shares of common stock under the Plan:


                                            Weighted                Weighted
                                             average      # of       average
                                     # of   exercise      shares    exercise
                                    shares    price    exercisable    price
                                    ------    -----    -----------    -----

Unexercised at January 1, 2000    4,056,716   $.52      3,426,716     $.52

    Granted/becoming exercisable     50,000    .50         25,000      .50
    Exercised                             0                     0
    Lapsed                           (1,500)   .50         (1,500)     .50
                                  ---------             ---------

Unexercised at March 31, 2000     4,105,216   $.52      3,450,216     $.52
                                  =========   ====      =========     ====



Common stock reserved for future issuance

     At March 31,  2000,  a total of  12,382,091  shares of  common  stock  were
reserved by the Company for issuance for the following purposes:


                         Purpose                                 # of shares
              -----------------------------                      -----------

Currently exercisable warrants:
 Exercisable at $.375 per share, expiring in June 2000               595,000
 Exercisable at $.50 per share, expiring in June 2000                595,000
 Exercisable at $.75 per share, expiring in
             December 2000                                           340,000
             February 2002                                           167,759
             March 2002                                              220,000
                                                                  ----------
                                                                   1,917,759

Currently exercisable options                                      3,450,216
Granted options becoming exercisable in the future                   655,000
Options available for future grants                                1,959,116
Conversion of preferred stock                                      4,400,000
                                                                  ----------

 Total shares reserved                                            12,382,091
                                                                  ==========


Note 7 - Commitments
- --------------------

     The Company occupies its office and laboratory facility on a month-to-month
basis  under the terms of an  operating  lease  agreement  pursuant to which the
property owner is required to provide thirty days notice if he wants the Company
to vacate the  premises.  The lease  provides  for monthly  rent of $4,000,  and
requires the Company to pay all property related expenses. The Company will seek
to negotiate a new long-term lease for its facility or search for an alternative
location  in the event  that an  agreement  cannot be reached  for the  existing
premises.  Management  believes  that the  resolution  of the  uncertainty  with
respect to the facility  will not result in a  significant  interruption  in the
operations of the Company.




















                                      - 9 -
<PAGE>
                        SONEX RESEARCH, INC. FORM 10-QSB



ITEM 2.  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL POSITION
                         AND RESULTS OF OPERATIONS


Caution regarding forward-looking statements
- --------------------------------------------

     Sections of this  Report,  as well as all  publicly  disseminated  material
about  the  Company,  contain  information  in  the  form  of  "forward-looking"
statements within the meaning of the Private  Securities  Litigation Act of 1995
(the  "Act").  Such  statements  are based on current  expectations,  estimates,
projections  and  assumptions by management with respect to, among other things,
trends affecting the Company's  financial condition or results of operations and
the impact of  competition.  Words such as  "expects",  "anticipates",  "plans",
"believes",  "estimates",  variations of such words, and similar expressions are
intended to  identify  such  statements  that  include,  but are not limited to,
projections of revenues, earnings, cash flows and contract awards. Such forward-
looking  statements are not guarantees of future  performance  and involve risks
and  uncertainties,  all of which are difficult to predict and many of which are
beyond the control of the Company.  Accordingly,  readers are  cautioned  not to
place undue reliance on such forward-looking statements.

     In order to obtain the benefits of the "safe harbor"  provisions of the Act
for any such  forward-looking  statements,  the Company  cautions  shareholders,
investors and prospective investors about significant factors which, among other
things,  have in some cases affected the Company's actual results and are in the
future  likely to affect the Company's  actual  results and cause them to differ
materially from those expressed in any such forward-looking statements.

     Factors that could cause actual results to differ materially  include,  but
are not limited to, the following:

      o    ability to generate cash flow from revenue or to secure financing
           necessary to fund future operations

      o    ability to demonstrate commercial viability of SCS technology

      o    ability to complete technology development and demonstration programs
           and execute licensing agreements that produce significant revenue

      o    ability to attract and retain skilled personnel

      o    changes in general economic conditions

      o    competition


The Company and its technology
- ------------------------------

      Sonex Research, Inc. ("Sonex" or the "Company"),  incorporated in Maryland
in 1980, has developed a patented proprietary  technology (the "Sonex Combustion
System", "SCS" or "Ultra Clean BurnTM technology") which improves the combustion
of fuel in engines  through design  modification of the pistons in large engines
or the cylinder heads in small engines.  Variations of the Company's  technology
have been applied to all types of internal combustion  engines,  including those
used in personal and commercial  vehicles  (automobiles,  trucks,  buses, boats,
motorcycles) as well as engines used in fixed or portable  utility  applications
(motor  generator  sets,  pumps,  chain  saws),  whether  spark  ignited (SI) or
compression ignited (CI), carburetted or fuel injected, using gasoline,  diesel,
alcohol and/or other fuels.

      Management  believes that the Company's  piston-based  emissions reduction
enabling technology for direct- injected (DI) diesel engines, which changes only
a single engine  component  while  introducing  no additional  parts,  can be an
alternative to exhaust aftertreatment.  Evidence to date shows that the SCS is a
significant  new  engine  design  variable,  and that the  synergy of the SCS in
combination  with  exhaust  gas  recirculation   (EGR)  can  enable  in-cylinder
emissions reduction to meet future regulatory standards.

      The Company's competition comes from the extensive research departments of
the world's major vehicle and engine manufacturers as well as independent engine
testing  firms.   Although  the  experience  and  financial   resources  of  its
competitors  far exceed those of the Company,  management  believes that the SCS
can  provide   significant   advantages   over  the  competition  on  price  and
performance.  Due to the highly competitive nature of the world's automotive and
truck industries, in connection with its contracts and/or demonstration programs
with such  manufacturers  the Company is required to execute  joint  secrecy and
disclosure  agreements  that  expressly  prohibit the public  disclosure  of the
customers' names and other significant information. Failure by Sonex to maintain
this strict level of  confidentiality  would  jeopardize the relationship of the
Company with its customers.




                                     - 10 -
<PAGE>
                        SONEX RESEARCH, INC. FORM 10-QSB



      The SCS for the reduction of exhaust  emissions in DI turbocharged  diesel
truck engines is being  commercialized  through  demonstration  and  development
programs  at  various  stages of  completion  with some of the  world's  largest
foreign  multi-national  diesel engine original equipment  manufacturers (OEMs).
The goal of such programs is to execute broad  agreements with the diesel engine
manufacturers  and their piston  suppliers  for  industrial  production of Sonex
pistons under license from the Company. The demonstration  process involves many
stages, from proof of concept using screw-assembled prototype pistons fabricated
in-house by Sonex and tested by the engine manufacturer in its laboratories,  to
working with piston  suppliers for the  fabrication  of finished  pre-production
pistons  that will be used in field  trials,  and in  durability,  manufacturing
optimization,  and  other  tests  required  before  the  start  of  full  series
production.

      In separate  demonstration  programs,  each of these OEMs has verified and
accepted that the SCS can substantially  reduce particulate  emissions at future
NOx  (oxides of  nitrogen)  levels in a DI diesel  engine for medium duty trucks
while  maintaining fuel  consumption and power.  Tests conducted by one of these
manufacturers  showed that an engine using  SCS-modified  pistons along with EGR
could attain future U.S. and European emissions targets when OEM type production
pistons become available. In-house testing of the Company's most recent patented
design innovation for vehicular DI diesel engines,  referred to as the "SCS-AD",
yields more impressive  results than earlier designs.  The SCS-AD,  when coupled
with EGR, achieves significant reductions in soot and NOx emissions with no fuel
penalty.

      Sonex  has now  reached  the next  stage  with  these  programs,  that is,
optimization of the piston design for the fabrication of pre-production pistons.
The engine  manufacturers  have stated that the SCS  benefits  could be in lower
cost and less  complexity.  These factors are now being addressed by the Company
and  its  customers.  Continued  revision  of  emissions  limits,  however,  has
challenged  Sonex to  produce  piston  designs  that  reduce  both NOx and soot,
leading to a delay in successful commercialization of the SCS.

      The Company also has  successfully  applied a patented SCS starting system
and  modified   combustion   chamber  design  to  the  conversion  of  reliable,
lightweight,  SI,  2-stroke,  gasoline  fueled  engines of various sizes used in
small, remotely controlled military unmanned aerial vehicles (UAVs) to start and
operate on JP-5 standard  military fuel (also referred to as "heavy fuel").  The
Sonex heavy fuel engines (HFEs) achieve power and fuel consumption substantially
equal to that of the stock gasoline engines and provide  dependable  performance
over the full engine operating range without "knocking",  which has been a major
shortcoming of other heavy fuel conversion technologies.

      As heavy fuels are less  volatile  than  gasoline,  in addition to the UAV
market,  the Company is examining a wide range of sustained  commercial  utility
engine  applications  for its heavy  fuel  conversion  technology  to reduce the
hazards  associated with the storage of gasoline in buildings and on boats. Over
the past few months, Sonex has also been applying its heavy fuel technology to a
4-stroke engine in connection with a contract with the U.S.
military.


Current diesel engine programs
- ------------------------------

      Funded  development of Sonex pistons for industrial  production,  using an
earlier SCS design,  for one of the foreign engine OEM's proceeded  successfully
through  verification  tests  by  the  engine  manufacturer  of  pre-production,
finished,  aluminum pistons using an earlier SCS design. In the first quarter of
this year, Sonex delivered  screw-assembled  pistons incorporating the SCS-AD to
the engine  manufacturer  for  testing in a complete  six-cylinder  engine.  The
manufacturer's  objective is to meet future  stringent  emissions  limits in the
production  version of this engine by use of the SCS technology,  in combination
with other fuel system improvements, with no exhaust aftertreatment devices such
as  catalytic  converters  or  particulate  traps.  Results  of these  tests are
expected in the near future. Management is hopeful that successful evaluation of
the Sonex pistons will lead later this year to  negotiations  for further design
optimization services and a license agreement.

      Promising   test  results  at  Sonex  of  the  SCS-AD  on  a  turbocharged
six-cylinder  DI diesel  engine  led a second  foreign  engine OEM to engage its
piston supplier to produce  pre-production SCS pistons. Sonex is providing input
into the piston design  process and delivery of the  pre-production  pistons for
further engine testing at the OEM is expected soon.

      Sonex has also  presented  the improved test results  demonstrated  by the
SCS-AD to U.S. diesel engine OEMs.  Last summer one of these U.S.  manufacturers
delivered to Sonex an engine used in current  production  sport utility vehicles
and  pick-up  trucks  for a  demonstration  of the  SCS in  that  engine.  Tests
conducted over the past few months at Sonex using SCS pistons in this engine are
progressing, and Sonex expects to provide a preliminary report on results to the
manufacturer later this year.



                                     - 11 -
<PAGE>
                        SONEX RESEARCH, INC. FORM 10-QSB



Heavy fuel engines (HFEs)
- -------------------------

      The Company has successfully converted small, SI, carburetted, two-stroke,
gasoline  fueled  engines of various  sizes used in small,  remotely  controlled
military  unmanned  aerial  vehicles  (UAVs) to start  and  operate  on  JP5/JP8
standard  military  fuels (also  referred  to as "heavy  fuels").  UAVs  conduct
short-range  tactical   reconnaissance  while  operating  virtually  unseen  and
unheard,  taking pictures of battlefields and enemy  installations  and relaying
them back to ground  forces.  Existing UAV engines in the  military's  inventory
operate on gasoline.  Because of safety and  logistics  concerns,  however,  all
military small engines, such as those powering UAVs, eventually will be required
to operate on less volatile,  widely  available heavy fuels used by jet aircraft
and most military vehicles.

      Under a "best efforts"  feasibility  demonstration  contract from the U.S.
Marine Corps (USMC)  Systems  Command in Quantico,  Virginia,  early in 1998 the
Company   delivered  five  prototype  UAV  heavy  fuel  engines  (HFEs).   Sonex
successfully converted the existing single cylinder, two-stroke, gasoline fueled
engine to start and run on heavy fuel,  leading  the USMC to  contract  Sonex to
convert an additional forty UAV engines used in the Dragondrone UAV. The USMC is
now deploying  tactical UAVs aboard ship for the first time, as the  Dragondrone
UAVs with Sonex HFEs are in service in several locations around the world. Other
demonstration  programs for the Sonex HFE  technology  for UAVs have taken place
under contract with the military and defense contractors as well.

      The Company is assessing additional potential uses by the military for the
SCS HFE  technology,  as well as private  sector  opportunities.  Operation of a
light-weight  engine on high flash point  fuels such as diesel and heavy  fuels,
will reduce the hazard associated with gasoline, making such an engine much more
suitable for  applications  where gasoline  storage is  undesirable,  such as in
diesel fueled utility  engines used in pumps,  generator  sets,  etc., in homes,
commercial  buildings and boats. Other military  applications for two-cycle HFEs
include standby generators,  water pumps, chainsaws,  earth tampers and outboard
engines.

     One such program on an alternative  HFE  application  is already  underway.
Under a sub-contract from a prime contractor to the U.S. military,  Sonex is now
completing  its  demonstration  of the  technical  feasibility  ofconverting  an
existing high performance, 650+ horsepower, 4-stroke, gasoline fueled propulsion
system for marine use to start and operate on heavy fuels. This demonstration of
the SCS 4-stroke HFE technology  has been conducted in a laboratory  feasibility
demonstrator  single-cylinder  engine at  Sonex.  The  feasibility  demonstrator
engine is starting and  operating on JP-5 over a wide range of engine speeds and
loads, with good fuel economy and without knocking.  Progress reviews to date by
the prime contractor and the military have been favorable;  soon, Sonex hopes to
receive  a  request  for  quotation  for  a  follow-up  contract  for  prototype
conversion, design enhancements, and installation and operational assessment.


Employees
- ---------

      As of March 31, 2000,  the Company had five  full-time  employees  and one
part-time  employee,  and engages the part-time services of two consultants on a
regular basis. Additional information on the Company's business, its technology,
and its  management  can be found in the  Company's  1999 Annual  Report on Form
10-KSB.


Financial position and liquidity
- --------------------------------

      As of March 31, 2000,  the Company had available  cash and  equivalents of
approximately $102,000 and accounts receivable of approximately $150,000, (which
includes  receivables of $130,000 from a prime contractor to the U.S. military).
Based upon  available  resources,  current and projected  spending  levels,  and
expected  revenue  from  current  and  anticipated   contracts,   management  is
optimistic  that the Company  will have  sufficient  capital to fund  operations
through December 31, 2000. In the event that the award of anticipated  contracts
is delayed or does not  materialize,  and in the absence of the  realization  of
significant  revenues,  additional  capital may be necessary to fund  operations
through and beyond that date. There is no assurance that such additional capital
will be available or, if available, can be obtained on favorable terms.


Results of operations
- ---------------------

      A net loss from  operations  of $72,595 was  recorded  for the first three
months of 2000, as compared to $201,201 for the corresponding  period in 1999, a
decrease of $128,606,  or 64%. The decrease in the loss was due to substantially
higher revenue in 2000 versus 1999.



                                     - 12 -
<PAGE>
                        SONEX RESEARCH, INC. FORM 10-QSB



      Revenue and cost of revenue:
      ----------------------------

                                      Three months ended March 31,
                                      ----------------------------
                                           2000          1999
                                           ----          ----

       Government                       $ 195,005     $  38,800
       Commercial                          20,000
                                        ---------     ---------
                                        $ 215,005     $  38,800
                                        =========     =========


       Cost of revenue                  $ 110,289     $  16,135
                                        =========     =========


     Since 1997 the Company has obtained  several  government  contracts for its
heavy fuel engine technology, an application that has been developed only in the
last few years.  All contracts to date in this area have involved the conversion
of commercial  gasoline  fueled engines used in UAV's and the like to heavy fuel
operation.  Commercial revenue earned in connection with the Company's DI diesel
engine piston  technology is subject to the negotiated  amount,  if any, that an
engine  manufacturer  is willing to provide in funding to  partially  offset the
development  costs  incurred by the Company in applying its technology to one of
the manufacturer's engines.

       All government  revenue reported for the first quarter of 2000 relates to
a sub-contract  awarded in the fall of 1999 from a prime  contractor to the U.S.
military pursuant to which Sonex is demonstrating  the technical  feasibility of
converting an existing high  performance,  650+ horsepower,  4-stroke,  gasoline
fueled  engine for marine use to start and operate on heavy  fuels.  The Company
has devoted a significant  portion of its available resources to the performance
of this  sub-contract  since  late in 1999.  Work  under  this  sub-contract  is
expected to be  completed in May 2000.  The Company is  currently in  discussion
with the prime contractor and the military for follow-up contracts for prototype
conversion, design enhancements, and installation and operational assessment.

       Government  revenue for the first quarter of 1999 was entirely related to
a January 1999 contract from the U.S. Naval Research Laboratory (NRL) for an HFE
conversion  demonstration on a gasoline UAV engine. Work on this contract, which
required only a small percentage of the Company's available workforce, continued
through the third quarter of 1999.

       Cost of revenue  primarily  consists of direct  labor  charges and direct
purchases  attributable to funded programs.  Such amounts were many times higher
in the  first  quarter  of 2000  than in 1999 due to the  relative  sizes of the
government  contracts being performed at the time. A small portion of total cost
of revenue for each period represented  charges directly  attributable to funded
commercial projects.


       Research and development (R&D) expenses:
       ----------------------------------------

       R&D expenses for the first three months of the year decreased by $38,967,
or 28%, from $140,462 in 1999 to $101,495 in 2000. While the number of employees
remained the same and compensation rates increased only slightly,  a much higher
percentage of the  workforce was devoted to funded  projects in 2000 as oppposed
to 1999.  Associated  charges  were  therefore  classified  as "Cost of revenue"
rather than R&D expenses for 2000.  The decrease in R&D expenses would have been
larger than reported except that the 2000 total includes  approximately  $25,500
for the write-off of unamortized  costs of patents  abandoned while there was no
such charge in 1999.


       General and administrative (G&A) expenses:
       ------------------------------------------

       Total G&A expenses for the first three months decreased by $7,588, or 9%,
from $83,404 in 1999 to $75,816 in 2000.  Personnel  costs declined from $55,787
in 1999 to $51,581 in 2000,  or $4,206,  primarily  as a result of a decrease in
wages for an  administrative  assistant,  which position  became vacant early in
1999 and has not since been filled.  Net decreases in other expenses amounted to
$3,382.









                                     - 13 -
<PAGE>
                        SONEX RESEARCH, INC. FORM 10-QSB



                           PART II - OTHER INFORMATION

ITEM 6.  EXHIBITS AND REPORTS ON FORM 8-K

  (a)    Exhibits:

           4      Instruments defining the rights of security holders (contained
                  in the  Articles of  Incorporation  and  By-laws,  as amended,
                  filed with the 1992 Annual Report on Form 10-KSB)

  (b)    Reports on Form 8-K:      None.



                                   SIGNATURES

     In accordance  with the  requirements  of the Exchange Act, the  Registrant
caused this report to be signed on its behalf by the  undersigned,  thereto duly
authorized.

                                 SONEX RESEARCH, INC.
                                  (Registrant)


                                            /s/ George E. Ponticas
                                         ----------------------------
                                by:      George E. Ponticas
                                         Chief Financial Officer


May 1, 2000

                                     - 14 -
<PAGE>

<TABLE> <S> <C>


<ARTICLE>                     5

<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               MAR-31-2000
<CASH>                                         102,197
<SECURITIES>                                         0
<RECEIVABLES>                                  149,992
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                               301,842
<PP&E>                                         493,786
<DEPRECIATION>                                 413,675
<TOTAL-ASSETS>                                 572,469
<CURRENT-LIABILITIES>                          145,508
<BONDS>                                              0
                                0
                                     15,400
<COMMON>                                       183,173
<OTHER-SE>                                    (548,037)
<TOTAL-LIABILITY-AND-EQUITY>                   572,469
<SALES>                                        215,005
<TOTAL-REVENUES>                               215,005
<CGS>                                                0
<TOTAL-COSTS>                                  287,600
<OTHER-EXPENSES>                                     0
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                                (71,993)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                            (71,993)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (71,993)
<EPS-BASIC>                                   ($.004)
<EPS-DILUTED>                                   ($.004)




</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission